Dronabinol and Ibrutinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dronabinol (dronabinol) and Ibrutinib (ibrutinib). Common drug interactions include diarrhoea among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Dronabinol and Ibrutinib. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Dronabinol?

Dronabinol has active ingredients of dronabinol. eHealthMe is studying from 5,453 Dronabinol users. Check the latest studies of Dronabinol.

What is Ibrutinib?

Ibrutinib has active ingredients of ibrutinib. eHealthMe is studying from 13,529 Ibrutinib users. Check the latest studies of Ibrutinib.



On Jul, 10, 2026

16 people who take Dronabinol and Ibrutinib together, and have interactions are studied.

Dronabinol and Ibrutinib drug interactions.

What are the common drug interactions of Dronabinol and Ibrutinib, by gender? *:

female:

  1. Diarrhoea
  2. Dehydration (dryness resulting from the removal of water)
  3. Hypokalaemia (low potassium)
  4. Vomiting
  5. Constipation
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Fatigue (feeling of tiredness)
  8. General physical health deterioration (weak health status)
  9. Nausea (feeling of having an urge to vomit)
  10. Oedema peripheral (superficial swelling)

male:

  1. Cardiac arrest
  2. Colitis (inflammation of colon)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  6. Hallucination, visual (seeing things that aren't there)
  7. Human herpesvirus 6 infection
  8. Impaired gastric emptying
  9. Klebsiella infection
  10. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

What are the common drug interactions of Dronabinol and Ibrutinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Diarrhoea
  2. Dehydration (dryness resulting from the removal of water)
  3. Hypokalaemia (low potassium)
  4. Vomiting
  5. Overdose
  6. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)

60+:

  1. Constipation
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Colitis (inflammation of colon)
  4. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  5. Anaemia (lack of blood)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  8. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  9. Delirium (wild excitement)
  10. Encephalitis (inflammation of the brain)

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 50.00%
  2. Seasonal Allergy (allergic condition due to certain season): 7 people, 43.75%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 37.50%
  4. Nausea (feeling of having an urge to vomit): 6 people, 37.50%
  5. Pain: 5 people, 31.25%
  6. Depression: 5 people, 31.25%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 18.75%
  8. Diarrhea: 3 people, 18.75%
  9. Indigestion: 2 people, 12.50%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Dronabinol and Ibrutinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dronabinol and Ibrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dronabinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ibrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dronabinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibrutinib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dronabinol and ibrutinib (the active ingredients of Dronabinol and Ibrutinib, respectively), and Dronabinol and Ibrutinib (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: